SEC Form 4 · accession 0000911916-16-000697

ZIMMER BIOMET HOLDINGS, INC. · ZBH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Group President

Period of report

Dec 1, 2016

Accepted (ET)

Dec 5, 2016 · 10:05 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001136869

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 1, 2016	M	5,050	$0.00	A	13,039	D
Common Stock^F2,F3	Dec 2, 2016	S	5,050	$101.1126	D	7,989	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F4,F5	—	Dec 1, 2016	M	5,050	D	—	—	Common Stock	5,050	0	D

F1Includes 1 share acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between August 1, 2016 and October 31, 2016, 5 shares purchased on October 28, 2016 under the dividend reinvestment plan for the Company's common stock, and 9 shares acquired between August 1, 2016 and October 31, 2016 through dividend reinvestment in Mr. Nolan's IRA.
F2Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Nolan on November 3, 2016.
F3Represents the sale of 5,050 shares in multiple transactions, ranging in price from $101.01 to $101.24 per share, resulting in a weighted average sale price of $101.1126. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F4Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
F5The RSUs vested on December 1, 2016.